Google Übersetzer
Herantis Pharma Plc
About
1.77EUR+0.00 +0.00%
Closed • Updated at 09:28 GMT+00:00Market Cap$54.42M
Volume4.8K
Beta0.64
RSI50.99
Herantis Pharma Plc — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 16 2026
Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases
Mar 5 2026
Herantis Pharma releases 2H and FY 2025 report today
Feb 19 2026
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
Jan 7 2026
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
Nov 26 2025
Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096
Recent Videos
Herantis Pharman yhtiökokous | Toimitusjohtajan katsaus 23.4.2026
Apr 24, 2026
19. huhtikuuta 2026
Apr 19, 2026
198. Bull, Bear & Beyond – Herantis Pharma: executive interview
Mar 23, 2026
Herantis Pharma – executive interview (19 March 2026)
Mar 19, 2026
Community Chat
Ask AI
Try asking